E-LIB Suche - Ergebnisse für: Dirnhofer, S

1

SAKK 38/19: ASSESSING A CTDNA AND PET‐ORIENTED THERAPY IN P..:

Stathis, A. ; Hitz, F. ; Schär, S....
Hematological Oncology. 41 (2023) S2 - p. 165-166 , 2023

Link: https://doi.org/10.1002/..

2

R‐CODOX‐M/R‐IVAC VERSUS DA‐EPOCH‐R IN PATIENTS WITH NEWLY D..:

Chamuleau, M. ; Stenner, F. ; Chitu, D....
Hematological Oncology. 41 (2023) S2 - p. 50-51 , 2023

Link: https://doi.org/10.1002/..

3

SAKK 35/14 RANDOMIZED TRIAL OF RITUXIMAB WITH OR WITHOUT IB..:

Østenstad, B. ; Pirosa, M. C. ; Schär, S....
Hematological Oncology. 41 (2023) S2 - p. 117-119 , 2023

Link: https://doi.org/10.1002/..

4

SAKK 36/13 ‐ IBRUTINIB PLUS BORTEZOMIB AND IBRUTINIB MAINTE..:

Novak, U. ; Fehr, M. ; Schär, S....
Hematological Oncology. 39 (2021) S2 - p. , 2021

Link: https://doi.org/10.1002/..

5

MUTATIONAL LANDSCAPE OF MARGINAL ZONE B‐CELL LYMPHOMAS OF V..:

Dirnhofer, S ; Vela, V ; Juskevicius, D..
Hematological Oncology. 39 (2021) S2 - p. , 2021

Link: https://doi.org/10.1002/..

6

INTEGRATION OF BASELINE METABOLIC PARAMETERS AND MUTATIONAL..:

Genta, S ; Ghilardi, G ; Cascione, L...
Hematological Oncology. 39 (2021) S2 - p. , 2021

Link: https://doi.org/10.1002/..

7

DEVELOPMENT AND VALIDATION OF A PET RADIOMICS PROGNOSTIC MO..:

Ceriani, L ; Milan, L ; Cascione, L...
Hematological Oncology. 39 (2021) S2 - p. , 2021

Link: https://doi.org/10.1002/..

8

Routinemäßige zielgerichtete Hochdurchsatzsequenzierung von..:

Menter, T. ; Dirnhofer, S. ; Tzankov, A.
Der Pathologe. 41 (2020) S2 - p. 143-148 , 2020

Link: https://doi.org/10.1007/..

9

INTEGRATION BETWEEN METABOLIC TUMOUR VOLUME AND METABOLIC H..:

Ceriani, L. ; Pirosa, M. ; Stathis, A....
Hematological Oncology. 37 (2019) S2 - p. 77-78 , 2019

Link: https://doi.org/10.1002/..

10

SAKK 35/15: A PHASE I TRIAL OF OBINUTUZUMAB IN COMBINATION ..:

Stathis, A. ; Mey, U. ; Schär, S....
Hematological Oncology. 37 (2019) S2 - p. 118-119 , 2019

Link: https://doi.org/10.1002/..

11

PROGNOSTIC IMPLICATIONS OF THE MICROENVIRONMENT IN FOLLICUL..:

Menter, T. ; Tzankov, A. ; Zucca, E....
Hematological Oncology. 37 (2019) S2 - p. 149-151 , 2019

Link: https://doi.org/10.1002/..

12

High-throughput sequencing of nodal marginal zone lymphomas..:

Pillonel, V. ; Juskevicius, D. ; Ng, C. K. Y....
Leukemia. 32 (2018) 11 - p. 2412-2426 , 2018

Link: https://doi.org/10.1038/..

13

WHOLE‐EXOME‐SEQUENCING OF NODAL MARGINAL ZONE LYMPHOMAS IDE..:

Pillonel, V. ; Juskevicius, D. ; Ng, C.K....
Hematological Oncology. 35 (2017) S2 - p. 149-149 , 2017

Link: https://doi.org/10.1002/..

14

Quality assurance trials for Ki67 assessment in pathology:

Raap, M. ; Ließem, S. ; Rüschoff, J....
Virchows Archiv. 471 (2017) 4 - p. 501-508 , 2017

Link: https://doi.org/10.1007/..

15

CHARACTERIZATION OF MEDIASTINAL LYMPHOMAS IN FEMALE SIBLING..:

Burkhard, R. ; Keller, I. ; Radpour, R....
Hematological Oncology. 35 (2017) S2 - p. 161-162 , 2017

Link: https://doi.org/10.1002/..